A detailed history of Tri Locum Partners LP transactions in Amgen Inc stock. As of the latest transaction made, Tri Locum Partners LP holds 82,271 shares of AMGN stock, worth $26.5 Million. This represents 6.64% of its overall portfolio holdings.

Number of Shares
82,271
Holding current value
$26.5 Million
% of portfolio
6.64%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $21.6 Million - $26.3 Million
82,271 New
82,271 $25.7 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $23.5 Million - $29.2 Million
107,480 New
107,480 $28.9 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tri Locum Partners LP Portfolio

Follow Tri Locum Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Tri Locum Partners LP with notifications on news.